ADAM8 and metastatic neoplasm: Lastly, a recent endpoint study of patient serum samples showed that increased miR-720 levels can be detected in the whole blood of breast cancer patients with metastatic disease [66], consistent with our data showing high ADAM8 expression in almost half of all metastases in breast cancer patients [24].